XML 106 R91.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair Value Measurements - Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Oct. 11, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Impairment of intangible assets $ 1,600 $ 28,700 $ 3,300  
Impairment loss on operating lease asset 1,400 1,500    
Investments in privately held companies 14,711 12,043    
Long-term notes receivable 2,345 2,196    
Allowance for expected credit losses 199 730    
Interest income 769 604 (291)  
NinePoint Medical, Inc.        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Impairment of equity method investment     20,500  
Impairment of property and equipment   359    
Write off of accrued interest     $ (1,600)  
Interest income 400 300    
Bluegrass Vascular Technologies, Inc        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Impairment of equity method investment   3,500    
Payment received on entire principal balance and all accrued interest $ 2,800      
Fusion Medical, Inc.        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Impairment of equity method investment   2,500    
Ownership percentage 19.50%      
Selio        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Ownership percentage       19.50%
Equity method investment       $ 2,600
ArraVasc Limited        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Impairment of intangible assets $ 1,600 4,800    
Impairment of property and equipment 1,300      
Director | Cianna Medical        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Contingent payments related to acquisition 800 1,000    
Other long-term obligations        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Contingent consideration liability, noncurrent 13,500 36,900    
Accrued expenses        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Contingent consideration liability, current $ 34,700 $ 18,800